PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

被引:421
|
作者
Zhang, Feng [2 ]
Ma, Jianglin [1 ]
Wu, Jiaxue [2 ]
Ye, Lin [2 ]
Cai, Hong [1 ]
Xia, Bing [1 ]
Yu, Xiaochun [2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; S-PHASE; PHOSPHORYLATION; ATM; BACH1; RECOMBINATION; CHECKPOINT; PARTNER; PROTEIN;
D O I
10.1016/j.cub.2009.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppressors play key roles in the DNA-damage response [1, 2]. However, it remains unclear whether these two tumor suppressor function together in the same DNA-damage response pathway. Here, we show that BRCA1 associates with BRCA2 through PALB2/FANCN, a major binding partner of BRCA2 [3]. The interaction between BRCA1 and BRCA2 is abrogated in PAL132-deficient Fanconi anemia cells and in the cells depleted of PALB2 by small interfering RNA. Moreover, we show that BRCA1 promotes the concentration of PALB2 and BRCA2 at DNA-damage sites and the interaction between BRCA1 and PALB2 is important for the homologous recombination repair. Taken together, our results indicate that BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 BRCA2.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [31] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Supriya Behl
    Nancy Hamel
    Manon de Ladurantaye
    Stéphanie Lepage
    Réjean Lapointe
    Anne-Marie Mes-Masson
    William D. Foulkes
    Scientific Reports, 10
  • [32] Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
    Takeuchi, Shoko
    Doi, Manami
    Ikari, Naoki
    Yamamoto, Masakazu
    Furukawa, Toru
    SCIENTIFIC REPORTS, 2018, 8
  • [33] Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
    Bychkovsky, Brittany L.
    Li, Tianyu
    Sotelo, Jilliane
    Tayob, Nabihah
    Mercado, Joanna
    Gomy, Israel
    Chittenden, Anu
    Kane, Sarah
    Stokes, Samantha
    Hughes, Melissa E.
    Kim, Ji Seok
    Umeton, Renato
    Awad, Mark M.
    Konstantinopoulos, Panagiotis A.
    Yurgelun, Matthew B.
    Wolpin, Brian M.
    Taplin, Mary-Ellen
    Newmark, Randall E.
    Johnson, Bruce E.
    Lindeman, Neal, I
    MacConaill, Laura E.
    Garber, Judy E.
    Lin, Nancy U.
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2349 - 2360
  • [34] Understanding the functions of BRCA1 in the DNA-damage response
    Yun, Maximina H.
    Hiom, Kevin
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 : 597 - 604
  • [35] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Behl, Supriya
    Hamel, Nancy
    de Ladurantaye, Manon
    Lepage, Stephanie
    Lapointe, Rejean
    Mes-Masson, Anne-Marie
    Foulkes, William D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] BRCA1 and BRCA2: super complex involved in repair of DNA damage?
    Feunteun, J
    M S-MEDECINE SCIENCES, 2001, 17 (10): : 1070 - 1071
  • [37] We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
    Yoshida, K
    Miki, Y
    CANCER SCIENCE, 2004, 95 (11): : 866 - 871
  • [38] Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
    Tsyganov, Matvey M.
    Sorokovikova, Sofia S.
    Lutzkaya, Elizaveta A.
    Ibragimova, Marina K.
    GENES, 2023, 14 (08)
  • [39] Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.
    Bychkovsky, Brittany L.
    Li, Tianyu
    Sotelo, Jilliane
    Tayob, Nabihah
    Mercado, Joanna
    Gomy, Israel
    Chittenden, Anu B.
    Kane, Sarah R.
    Stokes, Samantha
    Hughes, Melissa E.
    Kim, Ji Seok
    Awad, Mark M.
    Konstantinopoulos, Panagiotis A.
    Wolpin, Brian M.
    Taplin, Mary-Ellen
    Johnson, Bruce E.
    Lindeman, Neal Ian
    MacConaill, Laura E.
    Garber, Judy Ellen
    Lin, Nancy U.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway
    Chen, JJ
    Silver, D
    Cantor, S
    Livingston, DM
    Scully, R
    CANCER RESEARCH, 1999, 59 (07) : 1752S - 1756S